ELEVANCE HEALTH INC (ELV) Institutional Ownership

ELV is currently held by 12 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.66B based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is First Eagle U.S. Value, which reported ownership valued at approximately $1.21B in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, First Eagle U.S. Value's ELV position is now estimated to be worth approximately $1.63B, representing an estimated gain of +34.96% since the filing period.

Major shareholders tracked on this page include First Eagle U.S. Value, Eagle Capital Management, Sequoia Fund, and other prominent asset managers. Collectively, these investors account for approximately 94% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional position trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward ELEVANCE HEALTH INC (ELV).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 202612$2,655,830,36110,345,887
Q4 202511$3,071,290,39210,415,208
Q3 202511$3,178,363,88811,153,369
Q2 202512$3,080,757,1418,511,259
Q1 202511$3,679,006,0298,704,193
Q4 202411$3,181,547,6828,624,616
Q3 202411$3,834,941,9977,374,888
Q2 202411$3,803,155,0127,363,297
Q1 202412$3,526,146,1907,197,458
Q4 202312$3,305,210,6117,764,232
Q3 202313$2,913,358,2167,649,014
Q2 202313$3,130,162,6237,934,670